Prevalence of Fabry Disease among Patients with Parkinson’s Disease
Background. An increased prevalence of Parkinson’s disease (PD) disease has been previously reported in subjects with Fabry disease (FD) carrying alpha-galactosidase (GLA) mutations and their first-line relatives. Moreover, decreased alpha-galactosidase A (AGLA) enzymatic activity has been reported...
Saved in:
Main Authors: | Alexandra Lackova, Christian Beetz, Sebastian Oppermann, Peter Bauer, Petra Pavelekova, Tatiana Lorincova, Miriam Ostrozovicova, Kristina Kulcsarova, Jana Cobejova, Martin Cobej, Petra Levicka, Simona Liesenerova, Daniela Sendekova, Viktoria Sukovska, Zuzana Gdovinova, Vladimir Han, Mie Rizig, Henry Houlden, Matej Skorvanek |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2022/1014950 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fabry Disease and Early Stroke
by: U. Feldt-Rasmussen
Published: (2011-01-01) -
Major Organic Involvement in Women with Fabry Disease in Argentina
by: Fernando Perretta, et al.
Published: (2018-01-01) -
Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies
by: Cosimo A. Stamerra, et al.
Published: (2021-01-01) -
The Benefits of Early versus Late Therapeutic Intervention in Fabry Disease
by: Mónica Furlano, et al.
Published: (2022-01-01) -
A Survey of the Pain Experienced by Males and Females with Fabry Disease
by: Andrea L Gibas, et al.
Published: (2006-01-01)